Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis: Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis: Commentary'. Together they form a unique fingerprint.